Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients

This study has been completed.
Sponsor:
Collaborators:
Institut für Klinische und Molekulare Virologie
University of Erlangen-Nürnberg Medical School
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00284687
First received: January 31, 2006
Last updated: June 9, 2010
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)